The broader economic impact of vaccination: Reviewing and appraising the strength of evidence

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Jit, Mark ^a,b   Hutubessy, Raymond ^c   Png, May Ee ^d   Sundaram, Neisha ^d   Audimulam, Jananie ^d   Salim, Safiyah ^d   Yoong, Joanne ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cost effectiveness; Health economics; Immunisation; Systematic review; Vaccines

Indexed keywords

VACCINE;

ARTICLE; BUDGET; CHILD DEVELOPMENT; CONCEPTUAL FRAMEWORK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; ECONOMIC EVALUATION; EDUCATIONAL STATUS; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; PHYSICAL DEVELOPMENT; VACCINATION; COST BENEFIT ANALYSIS; ECONOMICS;

COST-BENEFIT ANALYSIS; HUMANS; VACCINATION;

EID: 84941260286     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0446-9     Document Type: Article

References (46)

1. Institute for Health Metrics and Evaluation. Development assistance for health, country and regional recipient level database 1990-2010. http://ghdx.healthdata.org/record/development-assistance-health-country-and-regional-recipient-level-database-1990-2010 . Accessed on 20 August 2015.
2. Plotkin SA. Vaccines: past, present and future. Nat Med. 2005;11:S5-S11.
3. Leach-Kemon K, Graves CM, Johnson EK, Lavado RF, Hanlon M, Haakenstad A. Vaccine resource tracking systems. BMC Health Serv Res. 2014;14:421.
4. Kim S-Y, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics. 2008;26:191-215.
5. Bloom DE, Canning D, Jamison DT. Health, wealth, and welfare. Finance Dev. 2004;41:10-5.
6. Belli PC, Bustreo F, Preker A. Investing in children's health: what are the economic benefits? Bull World Health Organ. 2005;83:777-84.
7. Bärnighausen T, Bloom DE, Canning D, O'Brien J. Accounting for the full benefits of childhood vaccination in South Africa. S Afr Med J. 2008;98:844-6.
8. Bärnighausen T, Bloom DE, Cafiero-Fonseca ET, O'Brien JC. Valuing vaccination. Proc Natl Acad Sci U S A. 2014;111:12313-9.
9. Bärnighausen T, Bloom D, Canning D. Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type B vaccine. Vaccine. 2011;29:2371-80.
10. Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health. 2012;12:878.
11. Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine. 2012;31:96-108.
12. World Health Organization. Report on the WHO consultation on the broader economic impact on vaccines and immunisation programmes (BEIVIP). Geneva: WHO; 2012.
13. Gavi. Internal review on wider economic benefits of vaccines. Board Retreat Paper. Geneva: Gavi; 2012.
14. Insinga RP, Dasbach EJ, Allen SE, Carides GW, Myers ER. Reductions in Human Papillomavirus-disease resource use and costs with quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study economic evaluation. Value Health. 2008;11:1524-4733.
15. Luce B, Zangwill K, Palmer C. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics. 2001;108:E24.
16. Loeb M, Russell M, Moss L, Fonseca K. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010;303:943-50.
17. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694-702.
18. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell; 2008.
19. Bloom DE, Canning D, Seiguer E. The effect of vaccination on children's physical and cognitive development in the Philippines. PGDA Working Papers, Program on the Global Demography of Aging. Cambridge: Harvard University; 2011.
20. Canning D, Razzaque A, Driessen J. The effect of maternal tetanus immunization on children's schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial. Soc Sci. 2011;72:1429-36.
21. Driessen J, Razzaque A, Walker D, Canning D. The effect of childhood measles vaccination on school enrollment in Matlab, Bangladesh. PGDA Working Papers, Program on the Global Demography of Aging. Cambridge: Harvard University; 2011.
22. Barham T, Calimeris L. Long-term effects of family planning and child health interventions on adolescent cognition: evidence from Matlab in Bangladesh. Institute of Behavioral Science Health and Society Program. Boulder: University of Colorado; 2008.
23. Kumar S. Childhood immunization, mortality and human capital accumulation: Micro-evidence from India. MPRA. 2009. http://mpra.ub.uni-muenchen.de/31806/ .
24. Bloom DE, Canning D, Weston M. The value of vaccination. World Econ. 2005;6:15-39.
25. Bishaia D, Koenig M, Khan M. Measles vaccination improves the equity of health outcomes: evidence from Bangladesh. Health Econ. 2003;12:415-9.
26. Rheingans R, Atherly D, Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine. 2012;30:A15-23.
27. Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine. 2013;31:4902-10.
28. Jeuland M, Lucas M. A cost-benefit analysis of cholera vaccination programs in Beira, Mozambique. World Bank Econ. 2009;2:899-908.
29. Edejer TT-T, Aikins M, Black R, Wolfson L, Hutubessy R, Evans DB. Cost effectiveness analysis of strategies for child health in developing countries. BMJ. 2005;331:1177.
30. Udezi W, Usifoh C, Ihimekpen O. Willingness to pay for three hypothetical malaria vaccines in Nigeria. Clin Ther. 2010;32:1533-4.
31. Palanca-Tan R. The demand for a dengue vaccine: a contingent valuation survey in Metro Manila. Vaccine. 2008;26:914-2.
32. Sauerborn R, Gbangou A, Dong H, Przyborski JM, Lanzer M. Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso. Scand J Public Health. 2005;33:146-50.
33. Sah R. The effects of child mortality changes on fertility choice and parental welfare. J Polit Econ. 1991;99:582-606.
34. Connolly M, Postma M. Health care as an investment: Implications for an era of ageing populations. J Med Mark. 2010;10:5-14.
35. Smith R, Keogh-Brown M, Barnett T, Tait J. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. BMJ. 2009;339:b4571.
36. Keogh-Brown M, Smith R. The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. Eur J. 2010;11:543-54.
37. Alsan M, Bloom DE, Canning D. The effect of population health on foreign direct investment inflows to low- and middle-income countries. World Dev. 2006;34:613-30.
38. Knodel J, Van de Walle E. Lessons from the past: policy implications of historical fertility studies. Popul Dev Rev. 1979;5:217-45.
39. Dahan M, Tsiddon D. Demographic transition, income distribution, and economic growth. J Econ Growth. 1998;3:29-52.
40. Connolly M, Constenla D. Assessing economic benefits for government and society attributed to malaria investment strategies: an exploratory analysis based on malaria vaccination. In: Proceedings of the multilateral initiative on malaria. 2009. www.gmasoln.com/downloads/Malaria.pdf .
41. Soares R. Mortality reductions, educational attainment, and fertility choice. Am Econ Rev. 2005;95:580-601.
42. Walker DG, Hutubessy R, Beutels P. WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine. 2010;28:2356-9.
43. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMC Med. 2013;11:80.
44. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices - overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force 1. Value Health. 2012;15:796-803.
45. Bhutta ZA, Das JK, Walker N, Rizvi A, Campbell H, Rudan I, et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013;381:1417-29.
46. Coast J, Smith RD, Lorgelly P. Welfarism, extra-welfarism and capability: the spread of ideas in health economics. Soc Sci Med. 2008;67:1190-8.